4//SEC Filing
Paolini John F. 4
Accession 0001415889-25-021346
CIK 0001730430other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 4:35 PM ET
Size
9.2 KB
Accession
0001415889-25-021346
Insider Transaction Report
Form 4
Paolini John F.
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Class A Ordinary Share
2025-08-06$3.80/sh+29,325$111,435→ 86,728 total - Exercise/Conversion
Share Option
2025-08-06−29,325→ 36,542 totalExercise: $3.80Exp: 2027-06-28→ Class A Ordinary Share (29,325 underlying) - Sale
Class A Ordinary Share
2025-08-06$32.55/sh−29,325$954,529→ 57,403 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 16, 2024.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.13 and $33.08. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- [F3]The option is fully vested and exercisable.
Documents
Issuer
Kiniksa Pharmaceuticals International, plc
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001741533
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 4:35 PM ET
- Size
- 9.2 KB